Single-Photon Emission Computed Tomography After Nitrate Administration Predicts Cardiac Events in Patients With Previous Myocardial Infarction and Left Ventricular Dysfunction

Journal of Cardiac Failure

Volumn 13, Issue 9, 2007, Pages 765-768

  Acampa, Wanda ^a   Evangelista, Laura ^c   Sorrentino, Anna Rita ^a   Petretta, Mario ^b   Luongo, Luca ^a   Cuocolo, Alberto ^a  

^a CNR   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c IRCCS SDN   (Italy)

Author keywords

Myocardial viability; nitrate imaging; prognosis

Indexed keywords

NITRATE;

ADULT; ARTICLE; CHI SQUARE TEST; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART DEATH; HEART EJECTION FRACTION; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROBABILITY; REVASCULARIZATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURVIVAL RATE;

ECHOCARDIOGRAPHY, STRESS; FEMALE; HEALTH STATUS; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; NITRATES; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR DYSFUNCTION, LEFT;

EID: 35748950400     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2007.05.007     Document Type: Article

References (17)

1. Allman K.C., Shaw L.J., Hachamovitch R., and Udelson J.E. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 39 (2002) 1151-1158
2. Udelson J.E., Bonow R.O., and Dilsizian V. The historical and conceptual evolution of radionuclide assessment of myocardial viability. J Nucl Cardiol 11 (2004) 318-334
3. Eitzman D., al-Aouar Z., Kanter H.L., vom Dahl J., Kirsh M., Deeb G.M., et al. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol 20 (1992) 559-565
4. Sciagrà R., Pellegri M., Pupi A., Bolognese L., Bisi G., Carnovale V., et al. Prognostic implications of Tc-99m sestamibi viability imaging and subsequent therapeutic strategy in patients with chronic coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 36 (2000) 739-745
5. Bax J.J., Visser F.C., Poldermans D., Elhendy A., Cornel J.H., Boersma E., et al. Relationship between preoperative viability and postoperative improvement in LVEF and heart failure symptoms. J Nucl Med 42 (2001) 79-86
6. Sorrentino A.R., Acampa W., Petretta M., Mainolfi C., Salvatore M., and Cuocolo A. Comparison of the prognostic value of SPECT after nitrate administration and metabolic imaging by PET in patients with ischaemic left ventricular dysfunction. Eur J Nucl Med Mol Imaging 34 (2007) 558-562
7. Schiller N.B., Shah P.M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., et al. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-dimensional Echocardiograms: recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echo 2 (1989) 358-367
8. Kaul S. Response of dysfunctional myocardium to dobutamine. The eyes see what the mind knows. J Am Coll Cardiol 27 (1996) 1608-1611
9. Cuocolo A., Acampa W., Nicolai E., Pace L., Petretta M., and Salvatore M. Quantitative thallium-201 and technetium-99m sestamibi tomography at rest in detection of myocardial viability in patients with chronic ischemic left ventricular dysfunction. J Nucl Cardiol 7 (2000) 8-15
10. Acampa W., Cuocolo A., Petretta M., Bruno A., Castellani M., Finzi A., et al. Tetrofosmin imaging in the detection of myocardial viability in patients with previous myocardial infarction: comparison with sestamibi and Tl-201 scintigraphy. J Nucl Cardiol 9 (2002) 33-40
11. Cox D.R. Regression models and life table. J R Stat Soc B 34 (1972) 187-220
12. Harrell F.E., Lee K.L., Califf R.M., Pryor D.B., and Rosati R.A. Regression modelling strategies for improved prognostic prediction. Stats Med 3 (1984) 143-152
13. The Multicenter Postinfarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med 309 (1983) 331-336
14. TIMI Study Group. Value of radionuclide rest and exercise left ventricular ejection fraction in assessing survival of patients after thrombolytic therapy for acute myocardial infarction: results of Thrombolysis In Myocardial Infarction (TIMI) phase II study. J Am Coll Cardiol 26 (1995) 73-79
15. Bax J.J., Poldermans D., Elhendy A., Boersma E., and Raimtoola S.H. Sensitivity, specificity, and predictive accuracies of various non-invasive techniques for detecting hibernating myocardium. Curr Probl Cardiol 26 (2001) 141-186
16. Chareonthaitawee P., Gersh B.J., Araoz P.A., and Gibbons R.J. Revascularization in severe left ventricular dysfunction: the role of viability testing. J Am Coll Cardiol 46 (2005) 567-574
17. Desideri A., Cortigiani L., Christen A.I., Coscarelli S., Gregori D., Zanco P., et al. The extent of perfusion-F18-fluorodeoxyglucose positron emission tomography mismatch determines mortality in medically treated patients with chronic ischemic left ventricular dysfunction. J Am Coll Cardiol 46 (2005) 1264-1269